New Concept and New Way of Treatment of Cancer Metastais

About the Book

“Immunotherapy has the potential to literally end cancer as we know it”, noted Vice President Joe Biden, who came to the Johns Hopkins in late April in 2016. We are excited about cancer immunotherapy is the excellent way to help the cancer patients to live longer and to have better quality of life because Dr. Xu Ze in China has been working on oncology immunotherapy more than decades. How did Dr. Xu Ze figure out all of these new concepts and new ideas of cancer treatment, especially immunotherapy? All of these came from his clinical practice and observation and from his animal experiments which showed that the host immune function decreased such as thymus (the place of T cells getting mature) atrophy while the cancer occurred etc. He did plenty of animal and clinical research of searching new ways and new medications for the oncology patients. We discussed to publish this book which is full of new concepts and new ways of cancer immunotherapy and shows that Xu Ze’s research group dedicates to cancer immunotherapy. The main contents of this book were written by Dr. Xu Ze in China many years ago after he did more than decades of research and oncology clinical practices. This book is full of the innovating ways and concepts how to stop the cancer metastases, especially the oncology immunotherapy and describes the metastases mechanism in details. In Chapter 11 and 21 the cancer cell immunotherapy was discussed in great detail. As we know, the cancer is also called malignancy tumor which are made up of cells that grow out of control. Cells in these tumours can inade nearby tissues and spread to other parts of the body which damages our normal function. This is known as metastasis or secondary cancer. If we stop the metastases, we can control cancer. This book described the cancer characteristics in details such as : development of tumor molecular biology; many factors which influence the occurrence and metastases of cancer in the body; Dr. Xu Ze’s immunotherapy methods and medications; each metastases step in details; the treatment of cancer thrombus; the review and prospect of oncology surgery; the new understanding of anticancer immunotherapy, etc. In brief, this book summarized Dr. Xu Ze oncology experience and all of his contribution to the oncology immunotherapy. In addition, because we finished this book during such shortly several months and this book is full of new concepts and broad knowledge, it may have some mistakes which please be forgiven by all of our reader and we also wish you can give us your feedback.

About the Author

Xu Ze, male, was born in Leping County of Jiangxi Province on October 1933. He graduated from Tongji Medical University in 1956 and successively held the post of director of the Department of Surgery of the affiliated hospital of Hubei College of Traditional Chinese Medicine. He is a professor, chief physician, tutor of postgraduate and doctoral student, president of Experimental Surgery Restitute Institute of Hubei College of Traditional Chinese Medicine, director of Abdominal Tumor Surgery Research Room, and director of Anti-carcinomatous Metastasis and Reoccurrence Research Room. In addition, he held concurrent posts of standing director of China Medical Association Wuhan Branch; vice president of Wuhan Micro-circulation Academy; academic member of International Liver Disease Research (Cooperation and Exchange Center); member of International Surgeon Union; standing member of first, second, third, and fourth editorial board of China Experimental Surgery Journal; standing member of first, second, and third editorial board of Abdominal Surgery Journal. He’s enjoying special allowance of the state council. He has been engaged in surgery work for forty-nine years and has accumulated rich experience in radical operation of lung cancer, esophageal carcinoma, liver cancer, carcinoma of gallbladder, adenocarcinoma of pancreas, gastric carcinoma, and intestinal cancer as well as in clinical therapy with Chinese traditional medicine combined with Western medicine for the prevention of reoccurrence and metastasis after operation. Xu Jie, male, graduated from the Department of Traditional Chinese Medicine of the Hubei University of Chinese Medicine in 1992 and from the Department of Clinical Medicine of Hubei Medical University (now the Medicine School of Wuhan University) in 1996, served as the associate chief physician of the surgery in the affiliated hospital of the Hubei University of Chinese Medicine (namely Hubei Hospital of Traditional Chinese Medicine), and engaged in study on experimental tumor of experimental surgery and the clinical work of general surgery and urinary surgery. Bin Wu, MD, PhD, graduated from the College of Yunyang of Tongji University of Medical Sciences for her MD degree and studied her master’s degree and her PhD degree in Sun Yat-Sen University of Medical Sciences. After she received her PhD, she worked as a postdoctoral fellow in the Johns Hopkins Medical School and University of Maryland Medical School. She passed all her USMLE tests and is going to do her residency training in America. She dedicates herself to oncology clinical research. Her goal is to conquer cancer, which she believes is a great contribution to our health. She has a daughter, Lily Xu.